Product Description
The book identifies treatment strategies that prolong patient s life and improve chances of survival through non-aggressive clinical forms. The author believes that breast cancer is determined by an unknown virus…. More >>
» Read more: Breast Cancer: Women’s Killer
Markers for Ovarian Cancer May Show Up Years Earlier
TUESDAY, Jan. 5 (HealthDay News) — Concentrations of several biomarkers begin to grow three years before women are diagnosed with ovarian cancer, but only reach substantial elevation levels over the 12 months before diagnosis, new research finds.
Read more on HealthDay via Yahoo! News
Competitive Technologies’ Calmare(R) Therapy Medical Device Treating Cancer Patients In Virginia
Competitive Technologies, Inc. announced that a premier physician oncology practice based in Virginia has begun using CTT’s Calmare® Therapy pain therapy medical device to treat patients suffering from pain related to cancer, under the direction of several medical oncologists.
Read more on News-Medical-Net